AVITA Medical Announces FDA 510(k) Clearance for Cohealyx, Expanding its Addressable Market [Yahoo! Finance]
Avita Medical, Inc. (RCEL)
Company Research
Source: Yahoo! Finance
AVITA Medical has received FDA 510(k) clearance for Cohealyx, a collagen-based dermal matrix designed to facilitate wound healing and tissue integration in full-thickness wounds. Cohealyx is expected to expand AVITA Medical's addressable market in burns, potentially tripling its market size, and will be launched commercially in the US in the second quarter of 2025. The product has shown promising preclinical results, with plans for a post-market clinical study to assess its performance in real-world settings. Cohealyx will be offered alongside AVITA Medical's RECELL and PermeaDerm products, enhancing the company's comprehensive portfolio for addressing full-thickness wound care. Generated by Yahoo Finance AI Yahoo Finance used generative AI to summarize key information from this article. Some details may be inaccurate. We take that seriously. Reporting mistakes helps us improve these summaries. Was this helpful? Yes No AVITA Medical New collagen-based dermal matrix desi
Show less
Read more
Impact Snapshot
Event Time:
RCEL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RCEL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RCEL alerts
High impacting Avita Medical, Inc. news events
Weekly update
A roundup of the hottest topics
RCEL
News
- AVITA Medical Announces FDA 510(k) Clearance for Cohealyx, Expanding its Addressable MarketGlobeNewswire
- AVITA Medical to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceGlobeNewswire
- miraDry Launches Female Leadership Exchange (FLEX) Initiative: Empowering Women in Medical Technology through Advocacy, Innovation, and Strategic Leadership [Yahoo! Finance]Yahoo! Finance
- AVITA Medical to Present at the Piper Sandler 36?? Annual Healthcare ConferenceGlobeNewswire
- AVITA Medical Announces Exclusive Distribution Agreement to Expand to Australia and New Zealand [Yahoo! Finance]Yahoo! Finance
RCEL
Earnings
- 11/7/24 - Miss
RCEL
Sec Filings
- 12/5/24 - Form 4
- 11/7/24 - Form 10-Q
- 11/7/24 - Form 8-K
- RCEL's page on the SEC website